Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable identical protein binding activity; nucleoside phosphate binding activity; and short-chain fatty acyl-CoA dehydrogenase activity. Predicted to be involved in butyrate catabolic process and fatty acid beta-oxidation using acyl-CoA dehydrogenase. Located in mitochondrion. Is expressed in several structures, including heart; liver; lung; pancreas; and placenta. Used to study short chain acyl-CoA dehydrogenase deficiency. Human ortholog(s) of this gene implicated in alcohol use disorder and short chain acyl-CoA dehydrogenase deficiency. Orthologous to human ACADS (acyl-CoA dehydrogenase short chain).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.